Inline Plastics v. EasyPak: CAFC rules asserted claims not limited to a specific embodiment

Each week, we succinctly summarize the preceding week of Federal Circuit precedential patent opinions. We provide the pertinent facts, issues, and holdings. Our Review allows you to keep abreast of the Federal Circuit’s activities – important for everyone concerned with intellectual property. We welcome any feedback you may provide.

– Joe Robinson, Bob Schaffer, and Tinh Nguyen




Federal Circuit Review Issue No. 65-01
Federal Circuit Finds Asserted Claims Not Limited to a Specific Embodiment

Inline Plastics Corp. v. EasyPak, LLC, No. 2014-1305, 2015 U.S. App. LEXIS 15117 (Fed. Cir. Aug. 27, 2015) (Before Newman, Clevenger, and Dyk, J.) (Opinion for the court, Newman, J.). Click Here for a copy of the opinion.

Inline Plastics Corporation (“Inline”) sued EasyPak for infringement of patents directed to tamper-resistant plastic food containers. During claim construction, the district court limited the claims to a preferred embodiment and construed the term “frangible section” to mean “a removable tear strip, delimited by at least two severable score lines” and the term “tamper evidence bridge” as a structure containing “a removable tear strip, delimited by at least two severable score lines.” Because EasyPak’s accused product only had a single severable score line, Inline moved for a final judgment of non-infringement, which the court granted. Inline then appealed the district court’s claim construction.

On appeal, the Federal Circuit held that the district court’s claim construction was not supported by the specification or the prosecution history. The specification described the invention’s features as “intended to prevent and deter opening container 10 without first removing frangible strip from hinge.” During prosecution, arguments made to overcome prior art were related to the “differences in the structure and opening mechanism as a whole” rather than the number of score lines. Therefore, there was nothing in the specification or the prosecution history to suggest that the number of score lines affected patentability of the claimed invention. In addition, the specification provided an alternative of “a single score line or perforation line, rather than a pair of score lines,” which the district court failed to consider. Since the preferred embodiment did not have patentable characteristics that are distinct from other disclosed embodiments, the Court held that “the patentee [was] entitled to claim scope commensurate with the invention that [was] described in the specification.”

The Court also held that the doctrine of claim differentiation was applicable here, since the “two severable score lines” limitation only appeared in a dependent claim but not in any independent claims. In other words, the presence of the “two severable score lines” limitation in a dependent claim gave rise to a presumption that such a limitation was not present in the independent claim. Therefore the district court erred when it required the asserted independent claims to have “at least two score lines or perforation lines.” Accordingly, the Court vacated the judgment of non-infringement and remanded.

The Author

Joseph Robinson

Joseph Robinson has over 20 years of experience in all aspects of intellectual property law. He focuses his practice in the pharmaceutical, life sciences, biotechnology, and medical device fields. His practice encompasses litigation, including Hatch-Waxman litigation; licensing; counseling; due diligence; and patent and trademark prosecution. He has served as litigation counsel in a variety of patent and trademark disputes in many different jurisdictions, and has also served as appellate counsel before the Court of Appeals for the Federal Circuit. Joe also focuses on complex inter partes matters before the U.S Patent and Trademark Office, inventorship disputes, reexaminations and reissues. His experience includes numerous interferences, a particular advantage in new U.S. Patent and Trademark Office post-grant proceedings. He also counsels on patent–related U.S. Food and Drug Administration issues, including citizen petitions, Orange Book listing, and trademark issues. For more information and to contact Joe please visit his profile page at the Troutman Sanders website.

Joseph Robinson

Robert Schaffer is an intellectual property partner at Troutman Sanders. Bob applies more than 30 years of experience to IP counseling and litigation. His work includes patent procurement, strategic planning and transactional advice, due diligence investigations, district court patent cases, and Federal Circuit appeals. He regularly handles complex and high-profile domestic and international patent portfolios, intellectual property agreements and licensing, IP evaluations for collaborations, mergers, and acquisitions. In disputed court cases Bob’s work includes representing and counseling client in ANDA litigations, complex patent infringement cases and appeals, and multidistrict and international cases. In disputed Patent Office matters his work includes representing and counseling clients in interferences, reexaminations, reissues, post-grant proceedings, and in European Oppositions. For more information and to contact Bob please visit his profile page at the Troutman Sanders website.

Warning & Disclaimer: The pages, articles and comments on do not constitute legal advice, nor do they create any attorney-client relationship. The articles published express the personal opinion and views of the author as of the time of publication and should not be attributed to the author’s employer, clients or the sponsors of Read more.

Discuss this

There are currently No Comments comments.